Fixed deductibles and low copays often mute patient price sensitivity for expensive care, making network design, utilization management, and value-based risk arrangements the main steering mechanisms.

In the final episode, Overcoming Barriers and Future Integration of Subcutaneous Therapies in Lung Cancer, the panelists ...

As reflected in its title, “Industry Payments to Cardiologists Are Associated With Higher Medicare Spending,” their ...

Delivering value-based oncology care requires both scientific breakthroughs and deliberate system redesign, experts concurred ...

Repeated-measures modeling found no consistent links between active atopic dermatitis and BMI, blood pressure, lipid profiles ...

Glucocorticoid exposure was linked to higher incident toxicity rates, including ≥1 toxicity (61.9% vs 52.3%) and ≥3 ...

Subcutaneous amivantamab offers faster treatment, fewer infusion reactions, and improved convenience for patients with ...

Continuous Medicare Advantage coverage was associated with higher last-year hospice enrollment (74.8%) and a ...

Myeloma delivery constraints are dominated by CAR T infrastructure and onboarding, while bispecifics are more ...

Marked geographic variation in opioid prescribing persisted, exemplified by Alabama’s historically high rates and subsequent ...

Marked interindividual variability in organ size at comparable BMI supports organ dimensions as a potentially superior ...

Even with significant organizational investment in cross-system coordination, primary care providers report a range of ...